Economic developer enterpriseSeattle opens Federal Way office


February 25, 2011 · Updated 10:20 AM 

  • 0
  • Print Story
  • Letter/Editor

Economic development services company enterpriseSeattle has established an office in Federal Way. The organization also added an office in Bellevue, while maintaining its presence in Seattle, in an attempt to expand its resources and services.

The company’s Federal Way office is located in the same building as the Cascadia MedTech Accelerator, a partner project between the city and enterpriseSeattle that is designed to help Federal Way self-create a cluster of medical device businesses. Cascadia is located at 33530 1st Way South, Suite 102.

EnterpriseSeattle provides free one-on-one, confidential consulting services to businesses seeking to establish, expand, or relocate to King County. The organization targets the aerospace, IT, life science, and clean technology industry sectors. It also focuses on foreign direct investment.  

“These new offices underscore the important work that we’re doing throughout the county and insures that our team of economic development professionals is embedded across the community,” said Jeff Marcell, President and CEO of enterpriseSeattle, in a prepared release. For more information about enterpriseSeattle, visit www.enterpriseSeattle.org.

 

Comment on this story.

COMMENTING RULES: We encourage an open exchange of ideas in our online community, but we ask you to follow our guidelines for respecting community standards. In a nutshell, don't say anything you wouldn't want your mother to read. Please see our FAQ if you have questions or concerns about using Facebook to comment.

So keep your comments:

  • Civil
  • Smart
  • On-topic
  • Free of profanity

We ask that all participants own their words by logging in with their Facebook account. It's a simple process that will take seconds and helps keep our comments free of trolls, cranks, and “drive-by” commenters. We reserve the right to remove comments from anyone using screen names, pseudonyms or false identities. Please refer to our Terms of Use for full detail on participating on our site.

blog comments powered by Disqus